Showing results (681-690 of 696) with videos related to
Sort By:
Pageof 70
Journal of Pharmacological and Toxicological Methods|May 26, 2005
Respiratory function in rats restrained for extended periods: assessment of the effects of bethanecolDavid Harris, Mags Graham, Joanne Price, et al.Scientific Reports|February 4, 2022
Energy homeostasis genes modify the association between serum concentrations of IGF-1 and IGFBP-3 and breast cancer riskRocío Rodríguez-Valentín, Gabriela Torres-Mejía, Louis Martínez-Matsushita, et al.Cancer Causes & Control : CCC|August 5, 2014
Associations between CYP19A1 polymorphisms, Native American ancestry, and breast cancer risk and mortality: the Breast Cancer Health Disparities StudyStephanie D Boone, Kathy B Baumgartner, Richard N Baumgartner, et al.Cancer Research|May 4, 2019
The Small GTPase ARF6 Activates PI3K in Melanoma to Induce a Prometastatic StateJae Hyuk Yoo, Samuel W Brady, Lehi Acosta-Alvarez, et al.Cancer Causes & Control : CCC|February 23, 2016
Red meat, poultry, and fish intake and breast cancer risk among Hispanic and Non-Hispanic white women: The Breast Cancer Health Disparities StudyAndre E Kim, Abbie Lundgreen, Roger K Wolff, et al.Breast Cancer Research and Treatment|September 17, 2013
Associations between genetic variants in the TGF-β signaling pathway and breast cancer risk among Hispanic and non-Hispanic white womenStephanie D Boone, Kathy B Baumgartner, Richard N Baumgartner, et al.Leukemia Research|May 30, 2001
Diagnostic criteria and classification of mastocytosis: a consensus proposalP Valent, H P Horny, L Escribano, et al.Genome Research|May 1, 1997
A 1.1-Mb transcript map of the hereditary hemochromatosis locusD A Ruddy, G S Kronmal, V K Lee, et al.The British Journal of Dermatology|July 24, 2004
Temozolomide and interferon alpha 2b in metastatic melanoma stage IVE Richtig, R Hofmann-Wellenhof, H Pehamberger, et al.Human Gene Therapy|May 1, 1999
Immunotherapy of metastatic malignant melanoma by a vaccine consisting of autologous interleukin 2-transfected cancer cells: outcome of a phase I studyS Schreiber, E Kämpgen, E Wagner, et al.Pageof 70